Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence For Outcomes Research in Crohn's Disease: Digital Pathology Assessment of Fibrosis and Association With Patient History and Clinical Outcomes

NCT07795476 is registered in ClinicalTrials.gov with PharmaNest, Inc as lead sponsor.

NCT NCT07795476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07795476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence For Outcomes Research in Crohn's Disease: Digital Pathology Assessment of Fibrosis and Association With Patient History and Clinical Outcomes
Lead sponsor
PharmaNest, Inc
Phase
Observational
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
May 15, 2027
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cd - crohn's disease, crohn disease, fibrostenotic crohn's disease